510(k) K261530

iiSure Infusion Set by Deka Research and Development — Product Code FPA

K261530 is an FDA 510(k) premarket notification submitted by Deka Research and Development for the device "iiSure Infusion Set". The FDA issued a decision of Substantially Equivalent on June 3, 2026. The device falls under product code FPA (Set, Administration, Intravascular), a Class II device regulated under 21 CFR 880.5440. Deka Research and Development has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 3, 2026
Date Received
May 8, 2026
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Set, Administration, Intravascular
Device Class
Class II
Regulation Number
880.5440
Review Panel
HO
Submission Type